← Back
$TEVA All transactions

TEVA PHARMACEUTICAL INDUSTRIES LTD

M 10b5-1 Plan

$ Value

Shares

620,110

Price

Filed

Feb 18

Insider

Name

Francis Richard D

Title

President and CEO

CIK

0001673277

Roles

Officer

Transaction Details

Transaction Date

2026-02-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

891,893

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. | The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2025. | Represents (1) with respect to the vesting of restricted share units, the reporting person sold all such shares vested, including shares to cover tax witholding obligations in connection with the vesting, and (2) with respect to the restricted share units granted subject to performance criteria, the reporting person sold such number of shares required to cover tax witholding obligations in connection with the vesting. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.015 to $34.51, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. | Restricted share units were granted on February 15, 2023, with 161,655 vested on each of February 15, 2024 and February 15, 2025, and 161,656 vested on February 15, 2026. | Restricted share units were earned on January 27, 2026, as a result of the satisfaction of certain performance criteria certified by the Human Resources and Compensation Committee and subsequently vested on February 15, 2026, following satisfaction of the time-based vesting criteria.

Filing Info

Accession No.

0001193125-26-056996

Form Type

4

Issuer CIK

0000818686

Francis Richard D's History

Date Ticker Type Value
2026-02-15 TEVA M
2026-02-15 TEVA $5.5M
2026-02-15 TEVA M
2026-02-15 TEVA $9.8M
2026-02-15 TEVA M $0
2026-02-15 TEVA M $0
2026-01-27 TEVA A $0
2026-01-27 TEVA A $0
2025-06-05 TEVA A $0

Other Insiders at TEVA (90d)

Insider Bought Sold Last
Francis Richard D
President and CEO
$15.3M 2026-02-15
Sabag Mark
See "Remarks"
2026-01-27
Daniell Richard
Exec. VP, European Commercial
2026-01-27
Kalif Eliyahu Sharon
EVP, Chief Financial Officer
$11.6M 2026-02-26
Hughes Eric A
See "Remarks"
2026-01-27